SCHEMBL19869017

SCHEMBL19869017

CCc1cccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.69
MAPK13 O15264 11/20 0.69
GCGR P47871 11/20 0.69
MAPK12 P53778 11/20 0.69
MAPK11 Q15759 11/20 0.69
ALOX5 P09917 11/20 0.69
CSNK1D P48730 3/20 0.66
PRKD3 O94806 2/20 0.66
MAP4K4 O95819 2/20 0.66
FRK P42685 2/20 0.66
MAPK9 P45984 2/20 0.66
CSNK1A1 P48729 2/20 0.66
GSK3B P49841 2/20 0.66
PTK6 Q13882 2/20 0.66
CLK4 Q9HAZ1 2/20 0.66
PRKD2 Q9BZL6 1/20 0.66
CSNK1E P49674 2/20 0.61
KDM4E B2RXH2 1/20 0.59
CIT O14578 1/20 0.59
GAK O14976 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2649680 0.87 MAPK11 (0.79) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL13061689 0.84 MAPT (0.60) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL2648558 0.82 MAPK14 (0.74) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL2649482 0.82 MAPK14 (1.00) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL19868922 0.81 MAPK14 (0.76) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL1387814 0.81 ALOX5 (1.00) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL6452661 0.81 MAPK14 (0.76) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL9195042 0.81 MAPK14 (1.00) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL4552316 0.81 MAPK14 (1.00) MAPK14MAPK13GCGRMAPK12MAPK11
SCHEMBL19868925 0.81 MAPK11 (1.00) MAPK14MAPK13GCGRMAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS UNIVERSITY OF NOTRE DAME DU LAC (US) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044316-A1 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS CREB1, PPP6R1, PPP1R10 MAPK14 440/4885MAPK13 782/4885GCGR 4261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.